Logos Global Management LP Q3 2021 Filing
Filed November 15, 2021
Portfolio Value
$1.4T
Holdings
57
Report Date
Q3 2021
Filing Type
13F-HR
All Holdings (57 positions)
| # | Stock | Shares | Value | % Portfolio | Type |
|---|---|---|---|---|---|
| 1 | ALXOALX ONCOLOGY HLDGS INC | 3,156,981 | $233.2B | 16.81% | |
| 2 | OLMAOLEMA PHARMACEUTICALS INC | 3,743,875 | $103.2B | 7.44% | |
| 3 | DCPHEURDECIPHERA PHARMACEUTICALS IN | 1,850,000 | $62.9B | 4.53% | |
| 4 | BCYCBICYCLE THERAPEUTICS PLC | 1,475,000 | $61.3B | 4.42% | |
| 5 | DYNDYNE THERAPEUTICS INC | 3,619,392 | $58.8B | 4.24% | |
| 6 | KRTXKARUNA THERAPEUTICS INC | 460,000 | $56.3B | 4.06% | |
| 7 | —FORMA THERAPEUTICS HLDGS INC | 2,115,000 | $49.0B | 3.54% | |
| 8 | APLSAPELLIS PHARMACEUTICALS INC | 1,450,000 | $47.8B | 3.45% | |
| 9 | IDYAIDEAYA BIOSCIENCES INC | 1,775,000 | $45.2B | 3.26% | |
| 10 | CMPSCOMPASS PATHWAYS PLC | 1,400,000 | $41.8B | 3.02% | |
| 11 | PMVPPMV PHARMACEUTICALS INC | 1,400,000 | $41.7B | 3.01% | |
| 12 | DSGNDESIGN THERAPEUTICS INC | 2,772,501 | $40.7B | 2.94% | |
| 13 | —DICE THERAPEUTICS INC | 1,160,251 | $38.0B | 2.74% | |
| 14 | CYTKCYTOKINETICS INC | 1,000,000 | $35.7B | 2.58% | |
| 15 | NKTXNKARTA INC | 1,275,777 | $35.5B | 2.56% | |
| 16 | KZRKEZAR LIFE SCIENCES INC | 4,100,000 | $35.4B | 2.55% | |
| 17 | ALGSALIGOS THERAPEUTICS INC | 1,962,785 | $30.4B | 2.20% | |
| 18 | ARNAEURARENA PHARMACEUTICALS INC | 510,000 | $30.4B | 2.19% | |
| 19 | VRDNVIRIDIAN THERAPEUTICS INC | 1,500,000 | $24.7B | 1.78% | |
| 20 | TILINSTIL BIO INC | 1,277,091 | $22.8B | 1.65% | |
| 21 | VERVVERVE THERAPEUTICS INC | 443,265 | $20.8B | 1.50% | |
| 22 | —LANDOS BIOPHARMA INC | 1,405,000 | $20.5B | 1.48% | |
| 23 | GRPHGRAPHITE BIO INC | 1,206,308 | $19.8B | 1.43% | |
| 24 | CNTACENTESSA PHARMACEUTICALS PLC | 1,069,545 | $17.9B | 1.29% | |
| 25 | TYRATYRA BIOSCIENCES INC | 1,003,394 | $17.6B | 1.27% | |
| 26 | —ATHIRA PHARMA INC | 1,855,812 | $17.4B | 1.26% | |
| 27 | IPSCCENTURY THERAPEUTICS INC | 639,095 | $16.1B | 1.16% | |
| 28 | JNCEEURJOUNCE THERAPEUTICS INC | 2,000,000 | $14.9B | 1.07% | |
| 29 | PRLDPRELUDE THERAPEUTICS INC | 400,000 | $12.5B | 0.90% | |
| 30 | IOVAIOVANCE BIOTHERAPEUTICS INC | 500,000 | $12.3B | 0.89% | |
| 31 | EWTXEDGEWISE THERAPEUTICS INC | 681,812 | $10.8B | 0.78% | |
| 32 | BMEABIOMEA FUSION INC | 702,320 | $8.4B | 0.61% | |
| 33 | ELDNELEDON PHARMACEUTICALS INC | 1,339,793 | $8.3B | 0.60% | |
| 34 | EPIEURESSA PHARMA INC | 1,000,000 | $8.0B | 0.58% | |
| 35 | ALTALTIMMUNE INC | 700,000 | $7.9B | 0.57% | |
| 36 | COGTCOGENT BIOSCIENCES INC | 925,000 | $7.8B | 0.56% | |
| 37 | BCELATRECA INC | 1,175,000 | $7.3B | 0.53% | |
| 38 | —TALARIS THERAPEUTICS INC | 507,923 | $6.9B | 0.50% | |
| 39 | —RAIN THERAPEUTICS INC | 465,331 | $6.6B | 0.48% | |
| 40 | CGEMCULLINAN ONCOLOGY INC | 288,458 | $6.5B | 0.47% | |
| 41 | GHRSGH RESEARCH PLC | 324,333 | $6.4B | 0.46% | |
| 42 | JANXJANUX THERAPEUTICS INC | 247,122 | $4.8B | 0.35% | |
| 43 | —SYNLOGIC INC | 1,500,000 | $4.6B | 0.33% | |
| 44 | NVLSEURALPINE IMMUNE SCIENCES INC | 425,000 | $4.5B | 0.33% | |
| 45 | STTKSHATTUCK LABS INC | 200,000 | $4.1B | 0.29% | |
| 46 | —IKENA ONCOLOGY INC | 299,853 | $3.8B | 0.27% | |
| 47 | DAWNDAY ONE BIOPHARMACEUTICALS I | 52,069 | $2.8B | 0.20% | |
| 48 | NUVLNUVALENT INC | 134,650 | $2.7B | 0.20% | |
| 49 | SLGCUSDSOMALOGIC INC | 200,493 | $2.2B | 0.16% | |
| 50 | —KINNATE BIOPHARMA INC | 94,345 | $2.2B | 0.16% | |
| 51 | —OMEGA THERAPEUTICS INC | 88,235 | $1.7B | 0.12% | |
| 52 | PASGPASSAGE BIO INC | 125,010 | $1.2B | 0.09% | |
| 53 | GLUEMONTE ROSA THERAPEUTICS INC | 50,000 | $1.1B | 0.08% | |
| 54 | KROSKEROS THERAPEUTICS INC | 15,000 | $593.0M | 0.04% | |
| 55 | RPTXREPARE THERAPEUTICS INC | 20,000 | $525.0M | 0.04% | |
| 56 | NUVB/WSNUVATION BIO INC | 66,666 | $177.0M | 0.01% | |
| 57 | MREOMEREO BIOPHARMA GROUP PLC | 46,984 | $114.0M | 0.01% |